associated with a high level of neutrophil infiltration and increased vascularization, and with poor prognosis in some Interleukin-8 (IL-8) is a chemokine for neutrophils and an cases (13-15). There have been a limited number of studies angiogenic factor. Human tumors that express IL-8 may in which the effect of IL-8 expression in experimental tumor exhibit intense neutrophil infiltration and increased vascumodels has been explored. IL-8 expression by CHO cells in a larization. Mutatect cells are a murine fibrosarcoma that nude mouse tumor model decreased subcutaneous tumorigeniccan be grown as subcutaneous tumors in syngeneic C57BL/ ity (20). The opposite effect of IL-8 expression was seen in 6 mice. Since neutrophils are a source of cytotoxic and human gastric carcinoma TMK-1 cells grown at an orthotopic genotoxic species, we constructed Mutatect cell lines that site in nude mice. IL-8 expressing TMK-1 cells produced constitutively express human IL-8 to explore the involverapidly growing and highly vascular tumors in the gastric wall ment of neutrophils in tumor biology and genetic instability.
(21). Thus, expression of IL-8 is found widely in tumors and An IL-8/neo expression plasmid was stably transfected into may have complex effects.
Mutatect MC17-51 cells and clone MIL-4 was isolated.
We have established the Mutatect model as an experimental Tumors initiated with 5⍥10 5 MIL-4 cells grew very slowly paradigm to study the biological role of neutrophils and compared with tumors from pure MC17-51 cells or from reactive nitrogen and oxygen species on genetic instability and 0.5 to 4⍥10 5 MIL-4 cells mixed with 5⍥10 5 MC17-51 cells.
tumorigenicity of a fibrosarcoma in syngeneic C57BL/6 mice Over 95% of cells recovered from slow-growing pure MIL-4 (22) . Mutatect tumors are infiltrated with host cells, predomitumors lost the transgene as measured by loss of (i) nantly neutrophils, and direct injection of IL-8 into tumors resistance to G418, (ii) expression of IL-8 protein and (iii) increased the number of infiltrating neutrophils (23). To explore IL-8-specific DNA sequences. When tumors from mixed the effect of IL-8 in Mutatect tumors in more detail, we have cell types were examined, loss of the transgene did not constructed Mutatect cell lines that constitutively express IL-8 occur; rather, IL-8 producing cells appeared to have some and describe the growth properties of tumors formed with growth advantage. The neutrophil content of tumors (as these cells as well as the stability of the transfected IL-8 gene. measured by myeloperoxidase) was directly proportional to the level of IL-8 expressed at the time tumors were Materials and methods excised. As reported earlier, the frequency of mutations at the hypoxanthine phosphoribosyltransferase locus was also C57BL/6 female mice. Mixed tumors were formed by inoculating mixtures of MC17-51 and MIL-4 cells as indicated in the table and figure legends. For in vitro controls, the same cell mixtures were grown in culture for the entire period of in vivo tumor growth, with subculturing twice weekly. Once the Abbreviations: Br-CL, bromide-dependent chemiluminescence; BSA, bovine tumors reached a measurable size (~1 week after injection), dimensions were serum albumen; CMV, cytomegalovirus; DMEM, Dulbecco's modified Eagle's estimated every 2-3 days. Tumor volumes were calculated from the equation medium; FCS, fetal calf serum; Hprt, hypoxanthine phosphoribosyltransferase; of a hemi-ellipsoid: IL-8, interleukin-8; MPO, myeloperoxidase; neo, neomycin-resistance gene; V ϭ (π·l·w·h)/6 PBS, phosphate buffered saline; PCR, polymerase chain reaction; rhIL-8, recombinant human IL-8; 6-TG, 6-thioguanine.
where V is the volume of the tumor in mm 3 . When the largest diameter of control MC17-51 tumors reached 1 cm (i.e.~21 days), all tumors were DMEM plus 0.1% FCS. IL-8 produced by Mutatect cell lines was quantified with reference to this standard curve. The assay was nearly linear in the range harvested. Each tumor (in 5 ml DMEM plus 10% FCS) was lightly minced and mechanically dispersed by passage through a syringe, then allowed to 0. (25) . This plasmid was first ent centrifugation followed by hypotonic lysis to remove erythrocytes (26) . Culture medium (0.5 ml) from transiently transfected Mutatect cells was digested to completion with NheI, then partially digested with EcoRI and finally blunt-ended with Mung bean nuclease to obtain an 833 bp fragment added to a 24-well plate. Nunc 10 mm Tissue Culture Inserts (Nalge Nunc International, Naperville, IL) with a 8 µm polycarbonate membrane were containing the entire coding region of IL-8. Mammalian expression vector pcDNA3 (Invitrogen, Carlsbad, CA) was digested with BamHI and bluntplaced into each well as the upper compartment of a Boyden chamber. A neutrophil-rich granulocyte suspension (0.4 ml containing 4ϫ10 5 cells in PBS ended with T4 DNA polymerase. The fragment and the vector were ligated to generate a construct containing the IL-8 coding region under a cytomegalovirus plus 0.9 mM CaCl 2 , 0.5 mM MgCl 2 and 0.1% BSA) was added into each insert. The plate was incubated at 37°C for 60 min to permit chemotaxis of (CMV) promoter. The vector also contained an ampicillin gene for bacterial selection and a neomycin (neo) gene for mammalian selection. The construct neutrophils through pores in the membrane. The membrane was removed, fixed in methanol, stained with hematoxylin, transferred to a glass cover slip, was transformed into competent SURE Escherichia coli (Stratagene Cloning Systems, La Jolla, CA) and ampicillin-resistant clones were selected. pcDNA3-air-dried and mounted on a glass slide with a drop of immersion oil such that the original lower surface of the membrane was uppermost. Neutrophils on IL8 (clone L25-13) was isolated. It was confirmed that it contained the IL-8 coding region in a sense orientation by restriction nuclease analysis and the this surface represent cells that have migrated through the pores of the membrane. The average number of neutrophils per ϫ400 magnification field correct nucleotide sequence by sequencing from the T7 promoter of pcDNA3. pcDNA3-IL8 is also referred to as the IL-8/neo trangene in this report.
was calculated from a count of eight fields. Experiments were carried out in duplicate.
Transfection of the IL-8/neo construct into Mutatect cells
Analysis of G418 R and Hprt -mutant cells MC17-51 cells were transfected with either pcDNA3-alone or pcDNA3-IL8 using liposomes. In transient transfection experiments, the culture medium
The percentage G418 R and the frequency of Hprt -mutant cells was measured in Mutatect cells growing ex vivo and in vitro. For estimating the percentage was analyzed after 48 h for IL-8. To produce stable transfectants, the pcDNA3-IL8 construct was linearized with ScaI before transfection into MC17-51 cells.
of cells expressing a functional neo gene, 200 viable cells were plated in triplicate on 6-cm dishes in the absence or presence of 500 µg/ml G418. After After 48 h in culture, 500 µg/ml G418 was added; G418-resistant (MIL) clones were selected and the culture media screened by ELISA for IL-8 8 days of incubation, the number of G418-resistant colonies was counted and the percentage of G418 R cells as a fraction of the total cells plated was production.
calculated. For estimation of the Hprt -mutation frequency, 1ϫ10 5 
viable cells Competitive ELISA for detection of IL-8 in culture medium
from each tumor were plated in triplicate in 10-cm dishes in medium containing A competitive ELISA was developed to permit sensitive detection of IL-8 in 50 µM 6-thioguanine (6-TG). After 14 days of incubation, the number of 6-the medium of Mutatect cells. Neutralite avidin (Molecular Probes, Leiden, TG-resistant colonies (representing Hprt -mutants) was counted and corrected The Netherlands) was bound (50 µl/well of 20 µg/ml in PBS at room for plating efficiency. Mutation frequency is the number of Hprt -mutants per temperature for 18 h) to a 96-well polystyrene microtitre plate, then blocked 1ϫ10 5 viable cells (24) . with 1% bovine serum albumen (BSA) for 2 h. Recombinant human IL-8
Detection of IL-8 gene loss by PCR (rhIL-8, from R&D Systems, Minneapolis, MN, supplied in solution as 300 µg/ml in 30 mg/ml BSA) was biotinylated as follows. A mixture was prepared Mutatect cells recovered from tumors (i.e. growing ex vivo) and in vitro controls were analyzed for loss of a fragment of the transfected gene. Genomic containing 0.1 M sodium borate (pH 8.8), 50 µM sulfosuccinimidyl biotin, 0.6 µg rhIL-8 and 60 µg BSA in 200 µl and allowed to react overnight at DNA was extracted and a 214 bp fragment from the integrated IL-8 transgene was amplified by polymerase chain reaction (PCR) analysis (forward primer, room temperature. Unreacted functional groups of sulfosuccinimidyl biotin were blocked with 5 mM ammonium chloride at room temperature for 30 GAGGCCTATATAAGCAGAGC; reverse primer, AGAGCTGCAGAAAT-CAGGAA). The 214 bp PCR product corresponded to 110 bp of the pcDNA3 min. Free biotin was removed by extensive dialysis against PBS. As a control, biotinylated BSA was prepared in a similar manner using a mixture lacking CMV promoter and 104 bp of the 5Ј end of IL-8 cDNA (i.e. the entire 5Ј untranslated region and the first 56 nt of the coding region). Failure to detect rhIL-8. Approximately 1 ng of dialyzed biotinylated rhIL-8 in 100 µl of ELISA buffer (0.02 M Tris-HCl, pH 7.5, 0.15 M NaCl, 0.05% v/v Tweenthe specific 214 bp PCR, while detecting a non-specific 670 bp fragment product on an ethidium bromide-stained agarose gel, was taken as evidence 20) was added per well of the avidin-coated, BSA-blocked 96-well plate and incubated at 4°C overnight. The wells were washed three times with ELISA of IL-8 gene loss. buffer and stored at 4°C for up to 1 month. Using anti-IL-8 antibody as
Tumor myeloperoxidase described below, bound biotinylated-rhIL-8 could be detected while avidinOne-tenth of each tumor cell suspension was centrifuged and resuspended in coated, BSA-blocked wells containing bound biotinylated-BSA, free rhIL-8 0.2 ml PBS. Cells were lysed by sonication; MPO was solublized by addition or no additive produced no signal.
of cetyltrimethylammonium bromide to 0.2%, followed by sonication. Protein Analysis of IL-8 in culture medium was carried out as follows. Cells were was quantified using fluorescamine (27), an amine-reactive fluorophore, as grown in DMEM plus 10% FCS at a density of 5ϫ10 4 /cm 2 . Eighteen hours described elsewhere (28) . MPO activity in the sonicates was measured by a before analysis, the medium was removed and replaced with DMEM plus specific assay based on bromide-dependent chemiluminescence (Br-CL) of 0.1% FCS. (Reducing the amount of FCS was found to lower the background luminol at pH 5 (29) . One unit of MPO activity is defined as the corrected and increase the sensitivity of the ELISA; data not shown.) The medium (0.5 Br-CL 3-min reading (29) . Each sample was assayed in triplicate. ml) was mixed with rabbit anti-human IL-8 polyclonal antibody (0.5 µl of 1 mg/ml, Endogen, Woburn, MA) and incubated overnight at 4°C. Wells were Reagents washed before use with ELISA buffer and 100 µl of culture medium Sulfosuccinimidyl biotin, p-nitrophenyl phosphate, fluorescamine, hypoxanpreincubated with anti-IL8 antibody was added and then incubated for 1 h at thine, aminopterin, thymidine, 6-TG, BSA and cetyltrimethylammonium room temperature. Unbound antibody was removed by three washes with bromide were from Sigma-Aldrich (Oakville, Canada). G418 was from ELISA buffer. Secondary antibody, 1:1000 diluted phosphatase-conjugated Gibco BRL. goat anti-rabbit IgG (Kirkegaard & Perry, Gaithersburg, MD) (100 µl/well) Statistical analysis was added and incubated for 1 h at 37°C. Wells were washed three times with ELISA buffer, 100 µl/well of substrate (3 mM p-nitrophenyl phosphate, For all statistical analyses, non-parametric tests were used. The Mann-Whitney U test was used to compare two unpaired groups. For three or more unpaired 50 mM Na 2 CO 3 , 0.05 mM MgCl 2 ) was added and color was allowed to develop overnight at 4°C. Absorbance was measured at 405 nm in a Benchmark groups, a Kruskal-Wallis test was used. Spearman rank correlation was used to determine a correlation between two measured variables. Curve fitting and Microplate Reader (Bio-Rad, Mississauga, Canada). For correction of nonspecific binding, the absorbance of wells without biotinylated-rhIL8 was statistical tests were performed using GraphPad Prism version 3.00 (GraphPad Software, San Diego, CA). A value of P Ͻ 0.05 was considered to be subtracted from the absorbance of corresponding biotinylated-rhIL8-coated wells.
statistically significant. In the figures, statistical significance is indicated as * (for P Ͻ 0.05), ** ( for P Ͻ 0.01) or *** (for P Ͻ 0.0001). A standard curve was constructed using 0-2 ng/ml of rhIL-8 added to 
IL-8 expression affects tumor biology

Construction of an IL-8-expressing cell line
initial experiment, the total number of cells was kept constant A human IL-8 cDNA clone from I.M.A.G.E. Consortium was at 5ϫ10 5 per inoculation, with varying ratios of the two cell used as the starting point to prepare an IL-8-expressing types (Table II) . With increasing numbers of MIL-4 cells and construct. The coding region was subcloned into a mammalian decreasing numbers of MC17-51 cells, the tumor volume was expression vector, pcDNA3, downstream of a CMV promoter.
progressively smaller. In a larger series involving 30 animals, To verify its ability to express biologically active IL-8, the cells were mixed in the following ratios and injected into six pcDNA3-IL8 construct was transiently transfected into Mutgroups of mice (five animals per group): 0:5, 0.5:5, 1:5, 2:5, atect MC17-51 cells; as a negative control, cells were trans-4:5 and 5:0 (ϫ10 5 MIL-4:MC17-51). The same cell mixtures fected with vector alone. IL-8 levels in the culture medium were also grown in vitro for an equivalent period of time. from transiently transfected cells were measured by ELISA.
Tumor volumes were monitored until excision at day 24 Medium from pcDNA3-IL8 transfected cells was estimated ( Figure 2B ). In agreement with the results shown in Figure  to contain~1.25 ng IL-8/ml; control medium (cell-free 2A and Table II , injection of pure MIL-4 cells (i.e. 5:0) medium) and medium from vector-transfected cells contained produced smaller tumors than any of the MIL-4/MC17-51 Ͻ0.1 ng/ml (Figure 1) . To test the biological activity of the mixtures (P ϭ 0.006), with growth kinetics indicating a lag expressed IL-8, an in vitro chemotaxis assay was carried out phase that was at least 1 week longer than pure MC17-51 using a Boyden chamber. Culture medium from pcDNA3-IL-8 tumors. Tumors initiated with the 0.5:5 mixture tended to transfected cells attracted significantly more human neutrophils grow more slowly than 0:5 (pure MC17-51) tumors, although than control medium (P Ͻ 0.0001) (Figure 1 ). These experithe difference was not statistically significant. Other combinaments demonstrate the ability of the pcDNA3-IL8 construct tions (1:5, 2:5 and 4:5) formed tumors whose growth was to express biologically active IL-8.
intermediate. (The growth curve of 2:5 tumors has been omitted pcDNA3-IL8 (which also contains a neo gene) was transfor clarity.) Thus, pure MIL-4 tumors grew very slowly and fected into Mutatect MC17-51 cells to construct stable cell the growth rate of MC17-51 tumors was modestly decreased lines that secrete IL-8. G418-resistant clones were selected by addition of 0.5-4ϫ10 5 MIL-4 cells. and screened for IL-8 expression (Table I) Figure 3A ). This provides further evidence that MIL-4 and MC17-51 cells have very similar growth rates in vitro.
Tumors formed from the same mixtures of MIL-4 and MC17-51 cells (as in Figure 2B ) were next examined to determine whether either cell type had a growth advantage in vivo. These tumors were excised at day 24 and cultured ex vivo in the absence or presence of G418. It was anticipated that the percentage of G418 R cells in mixed tumors would decrease, since tumors from 100% MIL-4 cells grew very slowly (see Figure 2 ). Contrary to expectation, the percentage of G418 R cells recovered from mixed tumors was as high or higher than corresponding in vitro cultures ( Figure 3A) , suggesting a growth advantage to the IL-8-expressing MIL-4 cells in mixed tumors. We then examined the level of ex vivo IL-8 expression in cells from the same set of tumors. IL-8 was measured in the culture media using ELISA. Cells from mixed MIL-4/ MC17-51 tumors produced a significant amount of IL-8, comparable with or even higher than corresponding in vitro mixed cultures ( Figure 3B ), again suggesting that MIL-4 cells had a growth advantage in mixed tumors.
G418 resistance and IL-8 expression in pure MIL-4 tumors
Pure MIL-4 cells formed very slow growing tumors ( Figure  2 ) but by day 24 at least 4ϫ10 6 viable cells could be recovered from each tumor. When examined for G418 resistance, it was found that the majority (Ͼ90%) of cells cultured ex vivo were sensitive to the drug while cells not passaged through the animal remained resistant ( Figure 3C ). Tumors were also initiated with a G418 R , non-IL-8-producing line (MIL-1) to determine whether the absence of IL-8 expression could influence loss of neo expression. As shown in Figure 3C , cells cultured ex vivo from MIL-1 tumors did not lose G418 resistance. This suggested that expression of IL-8 might be needed for high frequency in vivo loss of neo gene expression. Cells recovered from MIL-4 tumors were examined for their capacity to produce IL-8 in culture. It was found that, as with neo gene function, most cells had lost their capacity to produce IL-8 ( Figure 3D ). Taken together, these observations raised the possibility that the IL-8/neo transgene itself was very readily. Eventually, as mixed tumors grow in size, the number of infiltrating neutrophils relative to the tumor mass may be intratumoral neutrophils (23). The data shown in Figure 6 are insufficient to alter the course of tumorigenesis. We observed consistent with our earlier observations. When results from all enrichment of IL-8-secreting MIL-4 cells over MC17-51 cells tumors were pooled, there was a clear correlation between the in mixed tumors, which might be due to a growth advantage neutrophil content (MPO) and the Hprt mutant frequency.
conferred by IL-8-mediated angiogenesis (21) in MIL-4-rich segments of the tumor. The ultimate effect of IL-8 on the Discussion biology of a tumor may depend on its local concentration and on the presence or absence of other chemoattractant or IL-8 is a potent neutrophil chemokine and angiogenic factor, and expressed by many human tumors. Expression has been angiogenic factors in the tumor. The presence of phenotypic and genotypic markers in MILassociated with a high level of neutrophil infiltration, increased vascularization and poor prognosis (13-15). We have previ-4 cells allowed their fate to be studied in pure and mixed tumors. Tumors initiated with pure MIL-4 cells not only grew ously shown that direct injection of IL-8 into established Mutatect tumors can increase the number of infiltrating neutrovery slowly, with a long lag phase, but the small tumors that eventually did grow lost their IL-8/neo transgene with a phils, and that this is associated with an elevated mutation frequency in the tumor cells (23). To more closely model the remarkably high frequency. Despite the fact that the transgene is very stable in cultured MIL-4 cells, only Ͻ10% of cells situation that may exist in a human tumor, we constructed a Mutatect cell line (MIL-4) that constitutively expresses IL-8.
recovered from tumors were resistant to G418; their IL-8 level was also Ͻ10% of controls, and most cells appeared to have The presence of IL-8 expressing cells in tumors had a marked effect on their growth. Pure MIL-4 tumors grew very slowly lost the transgene (as measured by PCR). In striking contrast, the fate of the transgene in tumors initiated with mixtures of compared with pure non-IL-8 secreting MC17-15 tumors
